Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform Read more
FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer’s Disease Read more
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets Read more
Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics Read more
Simnova and Orna Therapeutics Collaborate to Advance Orna’s Next Generation Circular RNA Technology in China Read more
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications Read more
Capsida Biotherapeutics Announces Strategic Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Develop Non-Invasive Gene Therapies for CNS Diseases Read more